Loading insider details...
Beta
Latest Form 4 (Oct 8, 2026): Tax Withholding of 13,485 PHAT shares, $91.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Tax Withholding | 13,485 | $91.4K |
| Jan 2, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 82,715 | n/a |
| Oct 7, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 200,000 | n/a |
| Aug 14, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/Award | 17,251 | n/a |
| Mar 7, 2023 | Viatris Inc (VTRS) | Exercise/Conversion | 26,125 | n/a |
| Mar 2, 2023 | Viatris Inc (VTRS) | Exercise/Conversion | 21,246 | n/a |
| Mar 23, 2022 | Viatris Inc (VTRS) | Grant/Award | 251 | n/a |
| Mar 5, 2022 | Viatris Inc (VTRS) | Exercise/Conversion | 26,126 | n/a |
| Dec 23, 2021 | Viatris Inc (VTRS) | Grant/Award | 182 | n/a |
| Sep 24, 2021 | Viatris Inc (VTRS) | Grant/Award | 172 | n/a |